I don’t know why you presuppose the U.K. is where it would have had to be manufactured. Manufacture in the U.K. appears to have been made to happen at the insistence and investment of the U.K. government, from my recollection of a thread by an Oxford researcher involved.

There appears to be a similar deal with Novavax to setup similar domestic capacity in the UK for its vaccine.